Insulet's market cap is currently $23.59B. The company's EPS TTM is $1.17; its P/E ratio is 99.76; Insulet is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $1.15. See an overview of income statement, balance sheet, and cash flow financials.
